Consistently, in patients with nonalcoholic steatohepatitis (NASH), ChREBP expression is positively correlated with the degree of hepatic steatosis, but inversely related to IR [67]. Here, MLXIPL is linked to metabolic dysfunction-associated steatohepatitis.